{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:08:20Z","timestamp":1789776500428,"version":"4.0.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:00:00Z","timestamp":1404864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099461","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T19:28:11Z","timestamp":1404934091000},"page":"e99461","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Ergocalciferol and Microcirculatory Function in Chronic Kidney Disease and Concomitant Vitamin D Deficiency: An Exploratory, Double Blind, Randomised Controlled Trial"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct00882401","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Gavin","family":"Dreyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur T.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert M.","family":"Pearse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"a1618","DOI":"10.1136\/bmj.a1618","article-title":"Early detection of chronic kidney disease","volume":"337","author":"J Feehally","year":"2008","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"YC Li","year":"2002","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/1043-4666(92)90012-G","article-title":"1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level","volume":"4","author":"K Muller","year":"1992","journal-title":"Cytokine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"IH de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.jrn.2008.04.008","article-title":"Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients","volume":"18","author":"D Blair","year":"2008","journal-title":"J Ren Nutr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States","volume":"45","author":"RE LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies","volume":"58","author":"S Pilz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02640311","article-title":"Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate","volume":"6","author":"IH de Boer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","article-title":"25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification","volume":"20","author":"IH de Boer","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2011.10.023","article-title":"Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients","volume":"220","author":"N Chitalia","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease\u2014a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"A Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1681\/ASN.2006040367","article-title":"Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease","volume":"18","author":"S Tatematsu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1523-1755.2000.00936.x","article-title":"Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease","volume":"57","author":"B Pannier","year":"2000","journal-title":"Kidney Int"},{"key":"ref14","first-page":"IV31","article-title":"Surrogate markers for cardiovascular disease: functional markers","volume":"109","author":"JN Cohn","year":"2004","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"M Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"DL Andress","year":"2006","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"AB Shoben","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"F Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jsbmb.2006.11.009","article-title":"Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward","volume":"103","author":"M Wolf","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/0886022X.2011.553303","article-title":"Vitamin D status and mortality risk in patients with chronic kidney disease","volume":"33","author":"D Santoro","year":"2011","journal-title":"Ren Fail"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"F1059","DOI":"10.1152\/ajprenal.00051.2008","article-title":"Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells","volume":"294","author":"Y Talmor","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.34.4.897","article-title":"Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine","volume":"34","author":"AC Borges","year":"1999","journal-title":"Hypertension"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"H289","DOI":"10.1152\/ajpheart.00116.2008","article-title":"Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat","volume":"295","author":"MS Wong","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1741-7015-9-125","article-title":"Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial","volume":"9","author":"S Shab-Bidar","year":"2011","journal-title":"BMC Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","article-title":"Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels","volume":"25","author":"DJ Sugden J","year":"2007","journal-title":"Diabetic Medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1440-1797.2011.01555.x","article-title":"Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit?","volume":"17","author":"MM Assimon","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, <etal>et al<\/etal>.. (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant.","DOI":"10.1093\/ndt\/gfs138"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1549-8719.2011.00142.x","article-title":"Spotlight issue: Microcirculation-from a clinical perspective","volume":"19","author":"G Clough","year":"2012","journal-title":"Microcirculation"},{"key":"ref29","first-page":"193","article-title":"[Study of cutaneous microcirculation using the laser-Doppler method in syndrome X]","volume":"39","author":"P Pignocchino","year":"1994","journal-title":"Cardiologia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.metabol.2003.09.019","article-title":"Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes","volume":"53","author":"PA Economides","year":"2004","journal-title":"Metabolism"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2337\/diacare.14.11.958","article-title":"Skin reactive hyperemia in diabetic patients. A study by laser Doppler flowmetry","volume":"14","author":"E Tur","year":"1991","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mvre.2001.2325","article-title":"Primary cutaneous microangiopathy in heart recipients","volume":"62","author":"F Jung","year":"2001","journal-title":"Microvasc Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/cs1030267","article-title":"Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses","volume":"103","author":"QA Shamim-Uzzaman","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"ref34","first-page":"383","article-title":"Advances in the cardiovascular assessment of patients with chronic kidney disease","volume":"6","author":"JS McIntyre C","year":"2008","journal-title":"NDT Plus"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ki.2008.419","article-title":"Vitamin D in chronic kidney disease: is the jury in?","volume":"74","author":"IH de Boer","year":"2008","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease","volume":"42","journal-title":"Am J Kidney Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s005990070015","article-title":"Responses of the skin microcirculation to acetylcholine and to sodium nitroprusside in chronic uremic patients","volume":"30","author":"A Cupisti","year":"2000","journal-title":"Int J Clin Lab Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000045643","article-title":"Responses of the skin microcirculation to acetylcholine in patients with essential hypertension and in normotensive patients with chronic renal failure","volume":"85","author":"A Cupisti","year":"2000","journal-title":"Nephron"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/BF00401767","article-title":"Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM","volume":"38","author":"SJ Morris","year":"1995","journal-title":"Diabetologia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mvr.2003.12.003","article-title":"A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects","volume":"67","author":"EJ Droog","year":"2004","journal-title":"Microvasc Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ndt\/gfn634","article-title":"AGEs, autofluorescence and renal function","volume":"24","author":"EG Gerrits","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/cc6118","article-title":"How to evaluate the microcirculation: report of a round table conference","volume":"11","author":"D De Backer","year":"2007","journal-title":"Crit Care"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1073\/pnas.90.17.8103","article-title":"Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine","volume":"90","author":"LJ Ignarro","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"D de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Molina P, Gorriz JL, Molina MD, Peris A, Beltran S, <etal>et al<\/etal>.. (2013) The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol Dial Transplant.","DOI":"10.1093\/ndt\/gft360"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"R Thadhani","year":"2012","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2008-1212","article-title":"Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects","volume":"94","author":"O Tarcin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00860.x","article-title":"Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells","volume":"66","author":"G Rashid","year":"2004","journal-title":"Kidney Int"},{"key":"ref50","first-page":"1386","article-title":"Regulation of nitric oxide synthesis in uraemia","volume":"10","author":"M Arese","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2013.08.005","article-title":"Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - A randomised controlled trial","volume":"230","author":"MD Witham","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3945\/jn.113.175778","article-title":"Acute ingestion of beetroot bread increases endothelium-independent vasodilation and lowers diastolic blood pressure in healthy men: a randomized controlled trial","volume":"143","author":"DA Hobbs","year":"2013","journal-title":"J Nutr"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1479164113491275","article-title":"Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes","volume":"10","author":"S Tehrani","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Kaiser SE, Sanjuliani AF, Estato V, Gomes MB, Tibirica E (2013) Anti-Hypertensive Treatment Improves Microvascular Rarefaction and Reactivity in Low-Risk Hypertensive Individuals. Microcirculation.","DOI":"10.1111\/micc.12067"},{"key":"ref55","first-page":"203","article-title":"In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels","volume":"17","author":"F Pellegatta","year":"2006","journal-title":"Int J Mol Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T16:09:17Z","timestamp":1565626157000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099461"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Danilo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099461","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}